Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cort108297是一种选择性糖皮质激素受体调节剂,也是一种对其他类固醇受体无亲和力的选择性GR 拮抗剂。Cort108297对gr 具有较高的亲和力(Ki: 0.45 nM)。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 2,300 | 现货 | ||
5 mg | ¥ 5,260 | 现货 | ||
10 mg | ¥ 7,660 | 现货 | ||
25 mg | ¥ 11,300 | 现货 | ||
50 mg | ¥ 15,300 | 现货 | ||
100 mg | ¥ 19,800 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 6,390 | 现货 |
产品描述 | Cort108297 is a selective glucocorticoid receptor modulator and a selective GR antagonist with no affinity for other steroid receptors. Cort108297 showed a high affinity for GRs (Ki: 0.45nM). |
靶点活性 | GR:(ki)0.45 nM |
体外活性 | Cort108297 and CORT118335 had antagonistic effects on dexamethasone-induced KLK3 expression, which were 48% (p<0.05) and 60% (p<0.05), respectively. CORT118335(1µM) inhibited dexamethasone-induced SGK1 expression by 50%. However, Cort108297 was able to completely inhibit dexamethasone-mediated SGK1 elevation (p<0.05). After 3 days of dexamethasone ±SGRMs treatment in CWR-22RV1 cells, the induction effect of SGK1 gene expression was 100 times greater than that in re treated cells, while Cort108297 and CORT118335 completely inhibited this effect (p<0.01). Cort108297 and CORT118335 inhibited 70% and 75% of induction effects, respectively (p<0.01)[1]. |
体内活性 | At the end of the treatment period, mice treated with Cort108297(40 mg/kg BID) or Cort108297 (80 mg/kg QD) also have significantly lower steady plasma glucose than mice receiving vehicle[3]. Male rats are treated for five days with Mifepristone (10 mg/kg), Cort108297 (30 mg/kg and 60 mg/kg), Imipramine (10mg/kg) or vehicle and exposed to forced swim test (FST) or restraint stress. Experimental data showed that both doses of Cort108297 can effectively inhibit corticosterone response to FST and restraint stress, while only high dose of Cort108297 (60mg/kg) can significantly reduce immobility in forced swimming test (FST). [1]. |
分子量 | 535.55 |
分子式 | C26H25F4N3O3S |
CAS No. | 1018679-79-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 30 mg/mL (56.02 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 1.8672 mL | 9.3362 mL | 18.6724 mL | 46.681 mL |
5 mM | 0.3734 mL | 1.8672 mL | 3.7345 mL | 9.3362 mL | |
10 mM | 0.1867 mL | 0.9336 mL | 1.8672 mL | 4.6681 mL | |
20 mM | 0.0934 mL | 0.4668 mL | 0.9336 mL | 2.334 mL | |
50 mM | 0.0373 mL | 0.1867 mL | 0.3734 mL | 0.9336 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Cort108297 1018679-79-2 Endocrinology/Hormones Glucocorticoid Receptor Cort-108297 Inhibitor inhibitor inhibit